Two Sigma Investments, LP United Therapeutics Corp Call Options Transaction History

Two Sigma Investments, LP

12 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2022 May 16, 2022	SELL	$166.16 - $213.96 $498,480 - $641,880	-3,000 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$170.47 - $211.93 $1.18 Million - $1.46 Million	-6,900 Reduced 69.7%	3,000 $538,000
Q1 2020 May 15, 2020	BUY	$79.39 - $115.35 $150,841 - $219,165	1,900 Added 23.75%	9,900 $939,000
Q4 2019 Feb 14, 2020	BUY	$78.31 - $95.34 $195,775 - $238,350	2,500 Added 45.45%	8,000 $705,000
Q3 2019 Nov 14, 2019	BUY	$74.85 - $85.99 $112,274 - $128,984	1,500 Added 37.5%	5,500 $439,000
Q2 2019 Aug 14, 2019	BUY	$76.06 - $120.81 $76,060 - $120,810	1,000 Added 33.33%	4,000 $312,000
Q1 2019 May 15, 2019	SELL	$107.15 - $126.84 $107,150 - $126,840	-1,000 Reduced 25.0%	3,000 $352,000
Q3 2018 Nov 14, 2018	BUY	$113.81 - $129.46 $455,240 - $517,840	4,000 New	4,000 $512,000
Q2 2018 Aug 14, 2018	SELL	$101.14 - $118.31 $1.43 Million - $1.67 Million	-14,100 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$107.21 - $151.94 $1.19 Million - $1.69 Million	11,100 Added 370.0%	14,100 $1.58 Million
Q4 2017 Feb 14, 2018	SELL	$118.58 - $151.28 $260,876 - $332,816	-2,200 Reduced 42.31%	3,000 $444,000
Q3 2017 Nov 14, 2017	BUY	$114.6 - $136.81 $595,920 - $711,412	5,200	5,200 $609,000

676

42.1M

194K

295K

Ticker UTHR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,516,300
Market Cap $16.9B
Description
United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...

Get notified when there are updates to the investment portfolio of Two Sigma Investments, LP, based on Form 13F filings with the SEC.

Stay updated on Two Sigma Investments, LP with notifications on news.